Background: Psoriasis is a common, chronic inflammatory skin disease characterized by scaly white papules and
pinpoint bleeding on scratching. Presence of keratinocyte hyperproliferation and abnormal differentiation in the
epidermis are some significant features. Histopathologically, it is difficult for the dermatopathologists to differentiate
psoriasis from psoriasiform dermatitis when there is a lack of typical features. Aims: To study the Ki-67 antigen
expression in the different layers of epidermis of psoriatic skin lesion and its utility in the diagnosis and to differentiate
psoriasis from other psoriasiform dermatitis by studying the distribution pattern of Ki-67 immunostaining. Methods: In
this cross-sectional study, a total of 91 skin lesions which were clinically labelled as psoriasis and psoriasiform dermatitis
were studied, which was confirmed by histopathological examination and followed by Ki-67 immunostaining. The
distribution of Ki-67 immunostaining in the supra-basal layer, basal layer and whole epidermis was studied. Results: Ki67 staining was significantly higher in the suprabasal layer and whole epidermis in psoriatic lesions compared to
psoriasiform dermatitis. The suprabasal Ki-67 mitotic index was also significantly higher in psoriasis group than
psoriasiform dermatitis (p <0.05). We found that in psoriasis > 50% Ki-67 positive keratinocytes are scattered in the
suprabasal layer of the epidermis in comparison to the psoriasiform dermatitis which is < 50%. Conclusion: We
suggest that Ki-67 labelling index can be used for diagnosing psoriasis and also can differentiate it from other
psoriasiform dermatitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.